ArticleAbdominal radiology (New York)2026
Dual-energy computed tomography-derived extracellular volume fraction and spectral quantitative parameters for predicting early recurrence after gastrectomy: insights from a multicenter study.
Article in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeThis study aimed to develop and validate a nomogram integrating dual-energy computed tomography (DECT)-derived extracellular volume fraction (ECV), spectral quantitative parameters, morphological features, and clinical variables for predicting early recurrence (ER) after gastrectomy in patients with gastric cancer (GC). MATERIALS AND
methodsThis retrospective study included GC patients from three institutions. Two radiologists independently evaluated ECV, spectral quantitative parameters, and morphological features. Independent predictors were identified through logistic regression and used to construct a nomogram, DECT, conventional CT, and clinical models. The predictive performance of the nomogram was assessed using calibration curves, receiver operating characteristic (ROC) analysis, and decision curve analysis (DCA). The association between nomogram-predicted ER risk and recurrence-free survival (RFS) was evaluated using Kaplan-Meier survival analysis and Cox regression. A total of 354 patients were included in the study and stratified into a training cohort (n = 195), an internal validation cohort (n = 84), and an external validation cohort (n = 75).
resultsECV, arterial enhancement fraction (AEF), CT-detected extramural venous invasion (CT-EMVI), and neutrophil-to-lymphocyte ratio (NLR) were independently associated with ER. The nomogram yielded areas under the ROC curve (AUCs) of 0.894, 0.865, and 0.875 in three cohorts, outperforming the DECT, conventional CT, and clinical models. The nomogram showed good agreement between predicted and observed outcomes in all cohorts, as evidenced by non-significant Hosmer-Lemeshow test results (P > 0.05), and yielded favorable clinical utility according to decision curve analysis. Nomogram-predicted ER risk was independently correlated with RFS, and risk stratification based on the nomogram successfully identified high-risk patients with significantly worse 4-year RFS probabilities in all cohorts.
conclusionA nomogram incorporating ECV, AEF, CT-EMVI, and NLR provided an effective tool for predicting ER after gastrectomy in patients with GC.
Indexed as
Identifiers
42360349What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.